Cancers 2011, 3(1), 531-567; doi:10.3390/cancers3010531
Review

Protein Kinase C: An Attractive Target for Cancer Therapy

1 G. Gaslini Institute, L.go G. Gaslini 5, 16147, Genoa, Italy 2 Department of Experimental Medicine, General Pathology Section, University of Genoa, Via L.B. Alberti 2, 16132, Genoa, Italy
* Author to whom correspondence should be addressed.
Received: 23 December 2010; in revised form: 19 January 2011 / Accepted: 26 January 2011 / Published: 1 February 2011
(This article belongs to the Special Issue Cell Death and Cancer)
PDF Full-text Download PDF Full-Text [545 KB, uploaded 1 February 2011 09:37 CET]
Abstract: Apoptosis plays an important role during all stages of carcinogenesis and the development of chemoresistance in tumor cells may be due to their selective defects in the intracellular signaling proteins, central to apoptotic pathways. Consequently, many studies have focused on rendering the chemotherapy more effective in order to prevent chemoresistance and pre-clinical and clinical data has suggested that protein kinase C (PKC) may represent an attractive target for cancer therapy. Therefore, a complete understanding of how PKC regulates apoptosis and chemoresistance may lead to obtaining a PKC-based therapy that is able to reduce drug dosages and to prevent the development of chemoresistance.
Keywords: apoptosis; PKC; cancer; chemoresistance

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Marengo, B.; De Ciucis, C.; Ricciarelli, R.; Pronzato, M.A.; Marinari, U.M.; Domenicotti, C. Protein Kinase C: An Attractive Target for Cancer Therapy. Cancers 2011, 3, 531-567.

AMA Style

Marengo B, De Ciucis C, Ricciarelli R, Pronzato MA, Marinari UM, Domenicotti C. Protein Kinase C: An Attractive Target for Cancer Therapy. Cancers. 2011; 3(1):531-567.

Chicago/Turabian Style

Marengo, Barbara; De Ciucis, Chiara; Ricciarelli, Roberta; Pronzato, Maria A.; Marinari, Umberto M.; Domenicotti, Cinzia. 2011. "Protein Kinase C: An Attractive Target for Cancer Therapy." Cancers 3, no. 1: 531-567.

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert